| CASE REPORT |
|
| Year : 2013 | Volume
: 23
| Issue : 3 | Page : 214-216 |
Renal transplantation across ABO barrier
PN Gupta1, S Pokhariyal1, S Bansal1, S Jain1, V Saxena1, R Sharma1, M Jain1, P Jha1, SK Sethi1, P Ghosh1, A Tewari2, R Ahlawat1, V Kher1
1 Department of Nephrology, Medanta Institute of Kidney and Urology, Medanta the Medicity, Gurgaon, Haryana, India
2 Medanta Department of Transfusion Medicine, Medanta the Medicity, Gurgaon, Haryana, India
Correspondence Address:
P N Gupta
Department of Nephrology, Medanta the Medicity, Sector 38, Gurgaon -122 001, Haryana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0971-4065.111857
In India, patients without a compatible blood group donor are usually excluded from renal transplantation. For young patients, it is a difficult therapeutic choice to stay on long-term dialysis. We describe the case of a 19-year-old male patient who had blood group O +ve and had no compatible donor in the family. His mother was B +ve and was willing to donate. The patient had an initial anti-B antibody titer of 1:512 and underwent antibody depletion with plasmapheresis (11 sessions) and intravenous immunoglobulin (IVIG) 100 mg/kg after every plasmapheresis. He also received rituximab 500 mg for 3 days prior to transplant and was induced with basiliximab. At the time of transplant, his anti-B titers were <1:8. Post-operatively, he required four sessions of plasmapheresis and IVIG as his titers rebounded to 1:64. The titers then spontaneously subsided to <1:16 and have stayed at the same level for 6 months post-transplant. The patient continues to have normal renal function with a creatinine of 1.4 mg/dl% and has had no episodes of rejection.
[FULL TEXT] [PDF]*
|
|
Editorial Board
